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Our aim was to study the effect of estradiol (E2) on pulsatile
GnRH secretion in vitro in relation to sex and development.
When hypothalamic explants obtained from 5- and 15-d-old
female rats were exposed to E2 (107 M), a reduction of GnRH
interpulse interval (IPI) occurred but not at 25 and 50 d of age.
This effect was prevented by the estrogen receptor antagonist
ICI 182.780 and the AMPA/kainate receptor antagonist DNQX
but not by the AMPA and N-methyl-D-aspartate receptor an-
tagonists SYM 2206 and MK-801. E2 did not affect GnRH IPI in
hypothalamic explants obtained from male rats. Therefore,
the possible relation between the female-specific effects of E2
in vitro and perinatal sexual differentiation was investigated.
When using explants obtained from female rats masculinized
through testosterone injection on postnatal d 1, E2 was no
longer effective in vitro at 5 and 15 d. In addition, with ex-
plants obtained from male rats demasculinized through peri-
natal aromatase inhibitor treatment, E2 became capable of
decreasing GnRH IPI in vitro at 15 d. To study the possible
pathophysiological significance of early hypothalamic E2 ef-
fects, female rats received a single E2 injection on postnatal
d 10. This resulted in reduced GnRH IPI in vitro on d 15 as well
as advancement in age at vaginal opening and first estrus. In
conclusion, E2 decreases the GnRH IPI in the immature
female hypothalamus in vitro through a mechanism that
depends on perinatal brain sexual differentiation and that
could be involved in some forms of female precocious puberty.
(Endocrinology 145: 2775–2783, 2004)
IN CONDITIONS SUCH AS congenital adrenal hyperpla-sia (1, 2), sex-steroid-secreting tumors (3), or gonado-
tropin-independent sexual precocity (4, 5), the secondary
occurrence of central precocious puberty has led to the hy-
pothesis that sex steroids could promote hypothalamic mat-
uration. In addition, the different forms of central precocious
puberty are remarkably more frequent in the female than in
the male (6), suggesting that the female hypothalamus could
be more sensitive to triggering signals such as sex steroids.
Hypothalamic mechanisms, however, are difficult to study
in humans because they can only be assessed indirectly
through pituitary gonadotropin secretions that are directly
inhibited by a potent negative feedback, particularly in the
immature individual (7). In the rat, evidence has been pro-
vided that sexual maturation could be advanced after estro-
gen administration before puberty (8). Since we have set up
a rat hypothalamic explant paradigm in which developmen-
tal changes in frequency of pulsatile GnRH secretion can be
observed (9), we first aimed at studying the developmental
and sex-related effects of sex steroids in the hypothalamus in
vitro.
In previous studies, we found that the developmental
changes in frequency of pulsatile GnRH secretion in vitro
were associated with an increase in stimulatory glutamater-
gic inputs (10–12), an increase in activity of glutaminase (an
enzyme involved in glutamate biosynthesis) (13), and a re-
duction in prolyl endopeptidase activity that resulted in a
decreased inhibitory GnRH autofeedback mediated by the
GnRH1–5 degradation product through interaction at the N-
methyl-d-aspartate (NMDA) subtype of glutamate receptors
(12, 14). Moreover, in vivo studies in rats and monkeys have
shown the involvement of glutamate receptors in the exper-
imental induction of precocious puberty using NMDA re-
ceptor agonists and delayed puberty using NMDA receptor
antagonists (15–18). Our second aim was to study the pos-
sible involvement of glutamate receptors in estradiol (E2)
effects on GnRH secretion in vitro.
The impact of E2 on adult reproductive function depends
on brain sexual differentiation during the perinatal period
(19, 20). In females, neonatal injection of testosterone (T)
disrupts estrous cyclicity in the adult and induces male sex-
ual behavior (19). In males orchidectomized at birth, an LH
surge (20) can be induced by E2 treatment in adulthood, and
the male brain can also be demasculinized using an aro-
matase inhibitor within the first hours after birth (21, 22). Our
third aim was to determine whether perinatal sexual differ-
entiation could influence the effects of E2 on pulsatile GnRH
secretion in vitro. In addition, we aimed to study whether the
effects of E2 on GnRH pulse frequency in vitro could be
observed after E2 treatment of immature female rats in vivo
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Pregnant rats and 5-, 15-, 25-, and 50-d-old male and female Wistar
rats were purchased from the University of Lie`ge and housed under
standardized conditions (22 C, lights on from 0630 to 1830 h, food and
water ad libitum). Each litter contained nine pups, and weaning occurred
at the age of 3 wk. The day of birth was considered as postnatal d 1. All
experiments were carried out with the approval of the Belgian Ministry
of Agriculture and the Ethical Committee at the University of Liege.
The incubation medium MEM (phenol red-free MEM) was purchased
from Life Technologies, Inc. (Invitrogen Corp., Merelbeke, Belgium).
Sesame oil was purchased from VWR international (Leuven, Belgium).
The aromatase inhibitor ATD (1,4,6-androstatrien-3,17-dione) was pur-
chased from Steraloids Inc. (Newport, RI). The NMDA receptor antag-
onist MK-801 was obtained from Merck Sharp & Dohme research lab-
oratory (Rahway, NJ). The AMPA/kainate receptor antagonist DNQX
(6,7-Dinitroquinoxaline-2,3-dione), the AMPA receptor antagonist SYM
2206 (4-aminophenyl-1,2-dihydro-1-methyl-2-propylcarbamoyl-6,7-
methylenedioxyphtalazine) and the estrogen receptor (ER) antagonist
ICI 182.780 were purchased from Tocris (Fisher Bioblock Scientific,
Illkirch, France). 17-E2 and T were purchased from Sigma-Aldrich
(Bornem, Belgium); and R76713, racemic Vorozole, an aromatase inhib-
itor, was obtained from Janssen Pharmaceutica (Beerse, Belgium). All
steroids were dissolved initially in absolute ethanol and subsequently in
incubation medium to achieve a final ethanol concentration of 0.01%.
R76713 was initially diluted in 20% polyethyleneglycol (3.35 mg/ml)
and subsequently in the incubation medium to achieve a 105 m solution
containing 0.02% polyethyleneglycol. All the other drugs were diluted
directly in the incubation medium.
Hypothalamic explant incubation and hormone assays
The animals were rapidly decapitated between 1000 and 1100 h, and
trunk blood was collected. After decapitation, the retrochiasmatic hy-
pothalamus was rapidly dissected and transferred into a static incubator
as described in detail previously (23, 24). The medium consisted of
phenol red free MEM supplemented with glucose, magnesium, glycine,
and bacitracin (25 mm, 1 mm, 10 nm, 20m, respectively). The incubation
medium was collected and renewed every 7.5 min and kept frozen until
assayed. Each experiment included 12–16 hypothalamic explants, which
were incubated individually, each in a separate chamber. In each ex-
periment, at least two explants were incubated in MEM alone and used
as controls. GnRH was measured in duplicate using a RIA method with
intra- and interassay coefficients of 14 and 18%, respectively (24, 25). The
CR11-B81 anti-GnRH antiserum (final dilution, 1:80,000) was kindly
provided by Dr. V. D. Ramirez (Urbana, IL) (26). The data below the limit
of detection (5 pg/7.5 min) were assigned that value. After 4 h clotting
at room temperature, trunk blood was centrifuged (10 min at 1500 g).
Serum was collected and stored at 20 C until assayed. The LH assay
material was kindly provided by the National Institute of Diabetes and
Digestive and Kidney Diseases program. The samples were measured
in duplicate.
Study protocols
In vitro experiments. The effect of E2 on pulsatile GnRH secretion was
studied using explants obtained from female and male rats at 5, 15, 25,
and 50 d of age. The steroid was used for the whole 4-h experimental
period. The explants were incubated with 109–107 m E2 in initial
experiments. Subsequently, explants obtained from 15-d-old male and
female rats were used and incubated using 107 m E2. To study the
implication of ionotropic glutamate receptor subtypes, the antagonists
MK-801 (3.106 m), DNQX (106 m), or SYM2206 (106 m) were used
together with E2 or alone as control. The dosage of the antagonists was
selected based on previous experiments (23, 24). The effect of T was
studied by incubation with T (107 m). The aromatase involvement in
the T effect was studied through coincubation of T with the aromatase
inhibitor R76713 (105 m), which was also used alone as control. The
involvement of ER was studied using the ER antagonist ICI 182.780 (107
m) in the incubation medium together with E2 or alone as control.
In vivo experiments. In Fig. 1, a schematic summary of the in vivo exper-
iments is shown on an age scale.
Protocol A. Masculinization of female rats. On postnatal d 1, female pups
received either a single sc injection of 1.25 mg T in 100 l sesame oil (27)
or vehicle only, for control purposes. The animals were killed either on
postnatal d 5 or on d 15, and pulsatile GnRH secretion was studied in
vitro in the presence of 107 m E2 or in MEM alone.
Protocols B and C. Demasculinization of male rats. In protocol B, pregnant
rats were injected daily sc with the aromatase inhibitor ATD (5 mg in
FIG. 1. Schematic illustration of the in
vivo experiments, with treatment and
investigations represented on an age
scale.
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100 l sesame oil) from d 17–21 of gestation. In the control group,
pregnant rats were injected with vehicle. In the offspring, the male pups
were injected sc with 3 mg ATD in 50 l sesame oil on postnatal d 1, 6,
and 11 (28). The control rats were injected with the vehicle only. The
animals were killed either on postnatal d 5 or 15, and pulsatile GnRH
secretion was studied in vitro with or without the addition of 107 m E2.
In protocol C, ATD was administered as silicone implants (length, 5 mm;
inner diameter, 1.6 mm; outer diameter, 2.4 mm; Degania Silicone Sil-
clear tubing, Degania Bet, Israel). Within 5 h after birth, the pups were
anesthetized through ice-cooling and surgically implanted in the neck
(29). The animals were killed on d 15 to obtain the hypothalamic explants
and to study pulsatile GnRH secretion with or without 107 m E2.
Protocol D. Single E2 administration in immature female rats. Ten-day-old
female rats received a single sc injection of E2 (10 mg/kg given in 100
l sesame oil) (30, 31), which is comparable to the dose used by others
(32). This particular age was selected to be outside of the critical period
for sexual differentiation of the brain (31), and a single injection was
given to avoid the persisting negative feedback effect that could result
from repeated or prolonged administration. To increase the likelihood
of an effect after a single administration, we used a massive dose that
was greater than in the previous experiments showing induction of
precocious puberty (8). There were three groups of 14 rats injected either
with E2 or with sesame oil or saline. On d 15, five rats from each group
were killed to study pulsatile GnRH secretion in vitro in the absence of
any steroid in the incubation medium. Serum LH was also measured
using trunk blood. In the remaining animals, sexual maturation was
subsequently evaluated by daily examination for imperforation of the
vaginal membrane (vaginal opening, V.O.). Thereafter, vaginal smears
were taken every day in the afternoon until postnatal d 60. Slides of
vaginal smears were colored following the papanicolaou method and
examined to detect the occurrence of estrus cycle. The age at the first
estrus was considered when vaginal smears contained primary leuko-
cytes after the first proestrus phase, which was characterized by corni-
fied cells (33).
Statistical analysis
The mean LH levels (ng/ml) were calculated after log transform and
expressed as geometric mean.
GnRH secretory pulses were detected using the PULSAR program for
PC (basic version by S. Rosberg) (34). The cut-off criteria for peak de-
tection were determined empirically and were G1 2.5 and G2 2 (35).
Peak splitting parameter was set at 2.7, and the intraassay coefficient was
used as B coefficient (35). Data concerning the interpulse interval (IPI)
from different experiments were pooled and expressed as mean  sd.
The mean (sd) amplitude of GnRH secretory pulses was calculated
(pg/7.5 min fraction), and the data from different experiments were
analyzed separately by t test to avoid biases due to interassay variations
between experiments. In several instances, all the explants in a group
showed a similar GnRH IPI. Then, sd was zero and could not be rep-
resented in the figures. Similarly, when V.O. occurred at the same age
in all the rats in a control group, the sd was zero and could not be
represented. Significant effect of treatment was determined by t test
(control vs. E2 incubation). The effect of antagonist on control and treated
groups was determined by ANOVA test (one-way ANOVA) followed
by Newman-Keuls post test when the threshold for significance of dif-
ference (P  0.05) was reached.
Results
As shown in Fig. 2, incubation of individual hypothalamic
explants obtained in 15-d-old female rats with different E2
concentrations (109–107 m) resulted in a significant dose-
related decrease of GnRH IPI. E2 effectiveness occurred in
the nanomolar range as observed in other studies (36, 37). In
subsequent experiments, we used the highest concentration
because it was the most efficient in our paradigm. In explants
from 15-d-old male rats, no significant decrease of GnRH IPI
was caused by 107 m of E2 (Fig. 2). With explants from
5-d-old female rats, E2 (107 m) caused a significant decrease
in GnRH IPI, whereas no effect of E2 on pulsatile GnRH
secretion could be observed at 25 or 50 d in the female or at
any age studied in the male (Table 1). GnRH pulse amplitude
(mean sd, pg/7.5 min) was not affected by E2 at 5 d or 25 d
in both sexes. In 15-d-old female rats, discrepant data were
obtained because GnRH pulse amplitude was slightly, but
significantly, decreased in one experiment (mean ampli-
tude sd; controls, 9.9 0.2 pg/7.5 min; E2, 7.4 0.4 pg/7.5
min; t  5.657; df  16), whereas a significant increase in
amplitude was seen in a second experiment (controls, 10.3
0.4 pg/7.5 min; E2, 15.6  2 pg/7.5 min; t  7.7; df  19). In
a third experiment, amplitude was found to be higher and
more variable with no significant changes.
As previously reported (23, 35), the NMDA receptor an-
tagonist MK-801 resulted in a significant increase of GnRH
IPI (59  3 vs. 68  4 min, control vs. MK-801, Fig. 3) when
hypothalamic explants of 15-d-old rats were used. In con-
trast, the AMPA/kainate receptor antagonist (DNQX) or the
specific AMPA receptor antagonist (SYM 2206) did not affect
the GnRH IPI in similar conditions (control, 59  3 min;
FIG. 2. Representative profiles of pul-
satile GnRH secretion from six individ-
ual hypothalamic explants obtained at
15 d in female (left and middle panels)
and male (right panels) rats and incu-
bated in control conditions or together
with different concentrations of E2
(mean  SD). GnRH IPI is given to-
gether with the number of explants
studied in each condition (n). *, P 0.05
(controls vs. E2 108 M, t  6.127, df 
27; controls vs. E2 107 M, t 12.4, df
44). The limit of detection was 5 pg/7.5
min.
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DNQX, 60  4 min; SYM2206, 62  1 min). When similar
experiments were performed in the presence of 107 m of E2
(Fig. 3), the reduction of GnRH IPI caused by E2 was not
observed anymore in the presence of DNQX (59  2 min).
Using SYM 2206, the E2 effect was still observed (62 1 min
vs. 48 2 min, SYM 2206 vs. E2/SYM 2206). Likewise, the E2
effect was still observed in the presence of MK-801 (68  4
vs. 58  1 min, MK-801 vs. E2/MK-801). With hypothalamic
explants obtained from female rats and incubated in the
presence of the ER antagonist ICI 182.780, the reduction of
the GnRH IPI caused by E2 was absent (Table 2). T was as
effective as E2 in decreasing GnRH IPI in female explants,
and this effect was significantly prevented by an aromatase
inhibitor (R76713, 105 m) that had no effect when used
alone. When explants obtained from male rats were incu-
bated either with E2 or with T, no change in GnRH IPI was
observed (Table 2).
Because E2 could affect the GnRH IPI in the female only,
we studied the involvement of steroid imprinting in the
perinatal period. As shown in Fig. 4, after female rats were
androgenized through a sc injection of T on postnatal d 1, the
hypothalamic explants studied on d 5 and 15 did not show
any significant change in GnRH IPI when incubated with E2
(84  2 vs. 90  0 min at 5 d, 58  1 vs. 61  2 min at 15 d,
E2 vs. control). With control explants from female rats in-
jected neonatally with the vehicle, E2 could significantly
decrease the GnRH IPI in vitro at both ages (75  0 vs. 86 
10 min at 5 d, 45  6 vs. 56  7 min at 15 d, E2 vs. control).
When male rats were demasculinized through perinatal ad-
ministration of the aromatase inhibitor ATD, E2 caused a
significant decrease in GnRH IPI at 15 d (48 4 min vs. 60
0 min, E2 vs. control). A nonsignificant effect was observed
at 5 d (83  5 vs. 86  6 min, E2 vs. control). Using explants
from male rats treated perinatally with vehicle, E2 had no
effect on the GnRH IPI. To decrease the stress due to ma-
nipulation, we implanted male pups with a capsule contain-
ing ATD within 5 h after birth. In this case, the results ob-
tained were similar to those obtained in ATD-injected pups
(Table 3), which indicates that neonatal inhibition of aro-
matase activity is sufficient for E2 effect to occur.
After a single massive injection of E2 on d 10 in vivo, the
GnRH IPI studied in vitro on d 15 was found to be signifi-
cantly reduced (Fig. 5). On the same day, serum LH was
decreased in the E2-treated animals. In the E2-injected female
rats, the age at V.O. (27  1 d) and at first estrus (33  1 d)
was significantly advanced in comparison with controls in-
jected with vehicle (V.O., 31  1 d; first estrus, 37  2 d) or
saline (V.O., 33 0 d; first estrus, 38 1 d). Age at V.O. was
also advanced after vehicle injection when compared with
saline, but age at first estrus was not significantly different
between these two groups.
Discussion
The developmental increase in GnRH pulse frequency is
an important event for the pubertal changes in gonadotropin
secretion and has been observed in vivo in the female (38) and
the male rat (39) as well as in the female monkey (40) and in
vitro, using our rat explant paradigm (9). The critical age
period for such changes, however, was earlier in vitro (9) than
TABLE 1. Effect of E2 (107 M) on the IPI of pulsatile GnRH





Control Estradiol Control Estradiol
5 85  15 (15) 75  7a (14) 83  15 (11) 87  2 (11)
15 59  3 (24) 44  6a (22) 60  1 (11) 56  4 (11)
25 35  3 (6) 32  2 (7) 41  2 (6) 45  10 (8)
50 34  0 (3) 34  3 (3) 34  3 (3) 35  2 (3)
Data are mean SD (min, a P 0.05, E2 vs. control, 5-d-old female
rats: t  2.16, df  27; 15-d-old female rats: t  12.4, df  44).
FIG. 3. Effect of antagonists of NMDA
(MK-801), AMPA/kainate (DNQX), and
AMPA receptors (SYM 2206) on GnRH
IPI (mean  SD, min) using (n) hypo-
thalamic explants obtained from 15-d-
old female rats and incubated in control
conditions or with E2. NS, Nonsignifi-
cant; *, P  0.05 (MK-801, F  79.27,
df  3; DNQX, F  68.23, df  3;
SYM2206, F  67.69, df  3.
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in vivo (38, 39). Isolation of the hypothalamus could suppress
extrahypothalamic inhibiting inputs and account for earlier
manifestation of the accelerated GnRH pulse generator. In
this study, the developmental acceleration of pulsatile GnRH
secretion in vitro was found to be stimulated by E2 specifi-
cally in the immature female hypothalamus and through a
mechanism dependent on perinatal brain sexual differenti-
ation. In addition, E2 administration to immature female rats
in vivo resulted in both stimulation of pulsatile GnRH se-
cretion in the hypothalamus and subsequent precocious pu-
berty. The physiological significance of our data in the nor-
mal immature rat was uncertain due to normally limited or
absent exposure to sex steroids in such young animals. How-
ever, ultrasensitive E2 assay showed much higher plasma
levels in prepubertal girls than in boys, which was proposed
to be responsible for the faster maturation in girls than in
boys (41). Considering the abnormal early exposure to sex
steroids, our observations could provide a pathophysiolog-
ical basis for central precocious puberty occurring as a com-
plication of peripheral sexual precocity.
Using the rat model, we explored the possible pathophys-
iological significance of accelerated hypothalamic matura-
tion induced by abnormal early exposure to sex steroids, a
putative mechanism of central precocious puberty occurring
TABLE 2. Effect of E2 and testosterone and ER antagonist (ICI
182.781) and aromatase inhibitor (R76713) on the IPI of pulsatile
GnRH secretion in vitro using (n) 15-d-old rat hypothalamic
explants
Steroid antagonist Sex Control E2 (107 M) T (107 M)
None F 59  3 (24) 44  6a (22) 46  4a (6)
ICI 182.780 (107 M) F 61  1 (4) 57  1 (5)
R76713 (105 M) F 59  6 (4) 56  6 (4)
None M 60  1 (11) 57  2 (11) 51  4 (4)
Data are mean  SD (min, a P 0.05, control vs. E2: t  12.4, df 
44; control vs. T: t  11.36, df  28)
FIG. 4. E2 effect in vitro on the GnRH IPI (mean SD)
obtained using (n) hypothalamic explants from female
rats androgenized neonatally through sc injection of
1.25 mg T on postnatal d 1 (upper panel) and from male
rats treated perinatally using 5 mg of the inhibitor of
aromatase ATD injected daily sc to the dams on d
17–21 of gestation and 3 mg to the pups on postnatal
d 1, 6, and 11 (lower panels). *, P 0.05, control vs. E2
(5-d-old female rats, vehicle, t 2.379, df 8; 15-d-old
female rats, vehicle, t  2.484, df  6; 15-d-old male
rats, ATD, t  11;54, df  6).
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secondarily to peripheral precocity (1–4). In the female rat,
chronic treatment with low doses of E2 between postnatal d
5 and 30 resulted in early peripheral signs of puberty as
shown by early V.O. (42). Because administration of high
doses of E2 before d 10 caused brain masculinization with
loss of estrus cyclicity (19, 31), we elected to use a single E2
administration on d 10 to avoid interfering with this sexually
differentiated process, so that the timing of first estrus cy-
clicity, a presumably centrally driven pubertal event, could
be studied. The E2 administration in vivo resulted in a re-
duction of serum LH 5 d after E2 injection, which is in
agreement with pituitary negative feedback effects that char-
acterize immature female rats (42, 43). A decrease in the age
at V.O., as well as at first estrus, was also observed. These
results are in agreement with other findings (32) and point
out that the hypothalamic-pituitary-gonadal axis is sensitive
to E2 maturational effect in vivo both peripherally (V.O.) and
centrally (first estrus). In addition, the study of pulsatile
GnRH secretion in vitro provided evidence of concomitant
advance in the developmental acceleration of GnRH pulse
frequency that could account for subsequent occurrence of
central precocious puberty. This pattern was similar to sev-
eral clinical conditions such as congenital adrenal hyperpla-
sia (1, 2), sex steroid secreting tumors (3), and gonadotropin-
independent sexual precocity (4, 5), where central precocious
puberty occurred after treatment suppressing the peripheral
excess of sex steroids. So, these conditions account for with-
drawal of sex steroids after a period of exposure (6) such as
obtained here after an acute massive E2 administration.
E2 effects on GnRH neurons or GnRH secretion in the
hypothalamus were shown in several conditions using dif-
ferent paradigms. Using hypothalamic explants from adult
female monkeys, an increase in GnRH release was observed
in vitro 12 and 48 h after E2 treatment in vivo, whereas LH
secretion was reduced after 12 h and increased after 48 h (44).
Such a discrepancy between E2 effects on GnRH secretion in
vitro and gonadotropin secretion in vivo were consistent with
our in vivo data showing reduced serum LH levels and in-
creased frequency of pulsatile GnRH secretion 5 d after a
single E2 administration. This suggested a possible coexist-
ence of negative feedback effects at the pituitary level and
stimulating effects in the hypothalamus. Because E2 com-
monly resulted in inhibition of pulsatile LH secretion, par-
ticularly in immature rodents (45, 46), a concomitant stim-
ulating hypothalamic effect could be difficult to demonstrate
through the study of LH secretion. Noteworthy were some
possible inhibitory effects of E2 on the GnRH pulse generator
that could also occur as shown through electrophysiological
recording in the hypothalamus (47). A stimulating effect of
E2 on GnRH output in vivo was described in female rats (48)
and ewes (49). In these experiments, the mass of GnRH
release increased in possible relation to the preovulatory
GnRH and/or LH surge. However, these results were ob-
tained in adult ovariectomized animals (44, 48, 49), a con-
dition different from the present study in intact immature
rats. It is possible that stimulating effects of E2 observed in
vitro persist in the adult female rat but could not be observed
in the conditions of the present study. We showed earlier that
the amplitude of GnRH secretion by hypothalamic explants
obtained around 1600 h in cycling female rats was increased
in the afternoon of proestrus, presumably in relation with the
sex steroid induced preovulatory surge (50). For consistency
and practical reasons, all the experiments reported here were
carried out starting at 1000 h and in the absence of the
preoptic area. Further experiments that start at 1600 h with
explants obtained from adult female rats and including the
preoptic area are warranted to study the possible effects of
E2 on either GnRH pulse frequency and/or amplitude in
vitro. In this study, E2 increased GnRH pulse frequency
within minutes after starting incubation in vitro. Such a rapid
effect suggests a mechanism different from the preovulatory
surge and also deserves further studies. A rapid effect of E2
on LH secretion was reported in the ovariectomized female
guinea pig that was attributed to direct E2 effects on the
pituitary responsiveness rather than on the GnRH output
(51). Our data raises the question as to whether E2 acts
directly on GnRH neurons or on other target structures in the
hypothalamus to increase GnRH pulse frequency. Recently,
GnRH neurons were shown to express ER protein (52) and
ERprotein and mRNA (53). Using hypothalamic slices from
GnRH-GFP transgenic mice, E2 was able to decrease the
TABLE 3. Effect of perinatal inhibition of aromatase activity in
15-d-old male rats; ATD was delivered through silastic implants
with or without (control) aromatase inhibitor
Implants Control E2 (107 M)
Empty 59  1 (3) 58  1 (3)
ATD 60  0 (5) 48.9  2a (6)
Data are mean SD (min, a P 0.05, E2 vs. control, ATD implants:
t  10.73, df  3). N (n) explants were used in each condition.
FIG. 5. Effect of a single sc injection of E2 (10 mg/kg, postnatal d 10) in female rats on GnRH IPI in vitro (n  4 in each group, F  21.50, df 
2). Measurement of serum LH (n  5 in each group, F  7.094, df  2) as well as age at V.O. (n  10 in each group, F  133.2, df  2) and
age at first estrus (n  10 in each group, F  31.85, df  2). The control groups were injected sc either physiological saline (saline) or vehicle
(sesame oil). Data are mean  SD. *, P  0.05.
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GnRH neuron firing rate (54) and increase the number of
quiescent GnRH neurons (55), whereas membrane excitabil-
ity was increased as well (56). Although these observations
support a direct involvement of GnRH neurons in hypotha-
lamic effects of E2, we used retrochiasmatic explants where
GnRH cell bodies were virtually absent (57). Therefore, an
indirect E2 effect on GnRH secretion through interneurons or
glial cells could occur. Such cells have been shown to play an
important role in the control of GnRH secretion throughout
development (58). In addition, an E2 effect could occur in the
terminal part of GnRH neurons because, using median em-
inence explants, an increased output of basal GnRH release
was observed within 5–10 min of incubation with E2 (36).
Since the onset of puberty involves an activation of hy-
pothalamic glutamatergic inputs to GnRH neurons (59), we
evaluated glutamate receptor involvement in the E2-induced
decrease in GnRH IPI. As expected from the earlier demon-
stration implicating NMDA receptor activation in pulsatile
GnRH/LH secretion (16, 23), the NMDA receptor antagonist
MK-801 resulted in increased GnRH IPI in vitro. However,
MK-801 did not affect E2 stimulation of an increased GnRH
pulse frequency, suggesting that NMDA receptors were not
primarily involved in the mechanism of E2 effects. Previous
studies showed that non-NMDA receptors are involved in
adult female reproductive life, because nearly half of acti-
vated GnRH neurons expressed kainate receptor subunits in
the afternoon of proestrus (60). In addition, the AMPA/
kainate receptor antagonist DNQX can block the E2-induced
LH surge in OVX rats (61). In the present study, E2 stimu-
lation of GnRH pulse frequency was shown to involve spe-
cifically the kainate receptor subtype. As reported previously
(24), DNQX alone had no effect on pulsatile GnRH secretion
in vitro. Based on the evidence of an E2-kainate receptor
interaction involved in the control of GnRH secretion, the
absence of kainate receptor antagonist effect on the timing of
puberty could be explained by the silent role of such recep-
tors in the physiological absence of sex steroids in the im-
mature animal. The implication of kainate receptor in E2
effect was further supported by hypothalamic colocalization
of kainate receptor with ER (62). The preferential involve-
ment of kainate receptors in E2 effect on GnRH secretion in
vitro was consistent with the potentiating effect of E2 on
kainate-evoked currents in hippocampal neurons (63) or in
oxytocinergic neurons (37). The developmental disappear-
ance of E2 effect in the female rat hypothalamus could also
be linked to the developmental increase in activity of glu-
tamatergic inputs and/or decrease of GABAergic inputs
shown in the primate (64) and the rodent (10, 11, 35, 65). E2
was reported either to increase -aminobutyric acid (GABA)
turnover in relation with negative feedback effects (66) or to
decrease GABA levels just before the E2-induced LH surge
(67). In addition, kainate down-regulates GABA release in
mediobasal hypothalamic explants from ovariectomized fe-
male rats treated with E2 but not in untreated animals (68).
It could be hypothesized that E2 effects were involving the
GABAergic pathway because they were seen only in a period
of high activity of that inhibitory amino acid. Such indica-
tions of involvement of the GABAergic pathway in E2 effects
with developmental changes point to the need of further
studies using our in vitro paradigm.
An important finding was that the E2 stimulatory effects
on GnRH pulse frequency were only seen using hypotha-
lamic explants obtained from female rats but not using ex-
plants obtained from male rats. Such a sex-related effect was
not simply dependent on E2 because T was as effective as E2
in the female, provided that T could be aromatized into E2.
Further confirmation of the key role of E2 came from exper-
iments showing the inhibitory effect of ICI 182.780 on E2
stimulation of GnRH pulse frequency. Such an involvement
of ER was not inconsistent with the rapid, possibly non-
genomic effect of E2, because ICI 182.780 was shown to
prevent some rapid E2 effects such as those involving NO
(36). The sexual dimorphism of E2 effects could be related
with the sexually divergent effects of kainate on LH secretion
that was found to be inhibited in female rats and stimulated
in males (69). In addition, the occurrence of E2 effects in the
immature female rat could be related to the sexually dimor-
phic expression of ER that was reported in the rat hypo-
thalamus before 21 d of age (70). These developmental vari-
ations in ER expression are consistent with our observation
that this age period is characterized by a particular sensitivity
to E2 for increase in GnRH pulse frequency.
The dimorphic effects of E2 could depend also on sexual
brain differentiation. If so, we postulated that the E2 effect
should occur in hypothalamic explants from demasculinized
male rats, whereas this effect should be absent using hypo-
thalamic explants obtained from masculinized females. It
was well established that neonatal exposure to T or E2 in-
duced masculinization of female rats, resulting in disappear-
ance of female sexual behavior, absence of the E2-induced
LH surge (30), and the occurrence of a delayed anovulatory
syndrome in adult life (19, 31). In the male, blockade of
aromatase activity can induce appearance of female sexual
behavior (21, 28). Therefore, we used these two strategies to
investigate the possible early programming of the E2 effect
on GnRH pulse frequency that we had confirmed was oc-
curring. Such findings raised the issue of pre- or perinatal
programming of sexually dimorphic events that can be dif-
ferent among species. For instance, in the ovine species, the
timing of puberty is sexually dimorphic and is clearly af-
fected by fetal exposure to T (71).
In summary, evidence is provided in this paper that E2 can
rapidly stimulate an increase in GnRH pulse frequency in the
immature female hypothalamus. It is suggested that such a
mechanism can contribute to some form of sexual precocity,
a hypothesis which deserves further studies.
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